Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer
Marcus Moses, Alex Niu, Michael B. Lilly, Andrew W. Hahn, Roberto Nussenzveig, Elisa Ledet, Charlotte Manogue, Patrick Cotogno, Brian Lewis, Jodi Layton, Neeraj Agarwal, Oliver Sartor, Pedro C. Barata
Dive into the research topics of 'Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.